Enhertu combo shows promise in metastatic breast cancer while Arvinas reveals hopeful data on a novel lymphoma proteolysis …
Enhertu combo shows promise in metastatic breast cancer while Arvinas reveals hopeful data on a novel lymphoma proteolysis …
New safety and efficacy evidence supports expanded use of mavacamten in oHCM patients
The World Health Organization galvanized global efforts to make clinical trials faster, more inclusive, and deeply rooted in …
A key regulation is poised to reshape clinical research in Britain—reducing red tape, elevating patient voices and strengthening …
Clinical-stage companies AC Immune and Edgewise Therapeutics shared encouraging updates on their immunotherapy and cardiac medicine programs, signaling …
An established diagnostics firm gains critical funding to advance its wearable glucose monitoring technology and drive a strategic …
At ECCO 2025 in Berlin, Sanofi and Teva presented the first detailed findings from the RELIEVE UCCD study …
The FDA has cleared vimseltinib (Romvimza), a first-in-class CSF1R inhibitor, for symptomatic tenosynovial giant cell tumor—marking a breakthrough …
Parliament clears significant updates to the UK’s Clinical Trials Regulations—streamlining informed consent and laying the groundwork for improved …
New clinical-stage anti-obesity therapies began breaking ground—designed not just to shed pounds, but to retain muscle, offering a …
Already a subscriber? Log in